![Statement of changes in beneficial ownership - form 4](https://www.moneycontroller.it/upload/aziende/diamedica-therapeutics-inc_20210317153510.png)
FORM 4
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|
||||||||||||||||||||||||||||
|
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security | 8. Price of Derivative Security | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) | 11. Nature of Indirect Beneficial Ownership |
Code | V | (A) | (D) | Date Exercisable | Expriation Date | Title | Amount or Number of Shares |
Reporting Owners
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
Von Koch Thomas BIBLIOTEKSGATAN 25 3RD FLOOR STOCKHOLM, V7114 35 |
|
X |
|
|
TomEnterprise AB BIBLIOTEKSGATAN 25 3RD FLOOR STOCKHOLM, V7114 35 |
|
X |
|
|
TomEnterprise Private AB BIBLIOTEKSGATAN 25 3RD FLOOR STOCKHOLM, V7114 35 |
|
X |
|
Signatures
/s/ Thomas Von Koch | 2024-07-01 |
**Signature of Reporting Person | Date |
/s/ Thomas Von Koch, as Board Member of TomEnterprise AB | 2024-07-01 |
**Signature of Reporting Person | Date |
/s/ Thomas Von Koch, as Board Member of TomEnterprise Private AB | 2024-07-01 |
**Signature of Reporting Person | Date |
Explanation of Responses:
(*) | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
(**) | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | These shares are owned directly by TomEnterprise Private AB and indirectly by Thomas Von Koch in his capacity as the board member of TomEnterprise AB. Thomas Von Koch had the sole power to vote and dispose of these shares. |
Attachments
Disclaimer
DiaMedica Therapeutics Inc. published this content on 01 July 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 July 2024 20:38:28 UTC.